跳至主要内容
临床试验/IRCT2016110330678N1
IRCT2016110330678N1
已完成
未知

The effect of metacognitive therapy in patient with schizophrenia

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 5 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Schizophrenia.
发起方
Vice chancellor for research, Tehran University of Medical Sciences
入组人数
5
状态
已完成
最后更新
8年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
8年前
研究类型
Interventional
性别
All

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

入排标准

入选标准

  • Age 18 to 45 years; diagnosis of schizophrenia according to The Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 is approved by the psychiatrist's interview; Be educated at least secondary school (8 years); The patient has positive symptoms (symptoms are moderate to high in the initial tests); no change in medication over the past month and in the last two months has not received ECT; patient's condition is stable and no acute psychosis
  • Exclusion criteria: Borderline intellectual functioning or mental retardation based on the history and interviews; Drug or alcohol; Severe neurological disease (epilepsy, Parkinson's, dementia, Multiple sclerosis and any movement disorder); Forms of thought disorder, Hostility and extreme aggression; In case of worsening of symptoms or need to change the medication

排除标准

  • 未提供

结局指标

主要结局

未指定

相似试验